Cargando…
_version_ 1783737853179592704
author Ribas, Antoni
Algazi, Alain
Ascierto, Paolo A.
Butler, Marcus O.
Chandra, Sunandana
Gordon, Michael
Hernandez-Aya, Leonel
Lawrence, Donald
Lutzky, Jose
Miller, Wilson H.
Campbell, Katie M.
Delafont, Bruno
Marshall, Shannon
Mueller, Nancy
Robert, Caroline
author_facet Ribas, Antoni
Algazi, Alain
Ascierto, Paolo A.
Butler, Marcus O.
Chandra, Sunandana
Gordon, Michael
Hernandez-Aya, Leonel
Lawrence, Donald
Lutzky, Jose
Miller, Wilson H.
Campbell, Katie M.
Delafont, Bruno
Marshall, Shannon
Mueller, Nancy
Robert, Caroline
author_sort Ribas, Antoni
collection PubMed
description
format Online
Article
Text
id pubmed-8360951
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-83609512021-08-19 Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma Ribas, Antoni Algazi, Alain Ascierto, Paolo A. Butler, Marcus O. Chandra, Sunandana Gordon, Michael Hernandez-Aya, Leonel Lawrence, Donald Lutzky, Jose Miller, Wilson H. Campbell, Katie M. Delafont, Bruno Marshall, Shannon Mueller, Nancy Robert, Caroline Nat Commun Author Correction Nature Publishing Group UK 2021-08-12 /pmc/articles/PMC8360951/ /pubmed/34385448 http://dx.doi.org/10.1038/s41467-021-25285-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Author Correction
Ribas, Antoni
Algazi, Alain
Ascierto, Paolo A.
Butler, Marcus O.
Chandra, Sunandana
Gordon, Michael
Hernandez-Aya, Leonel
Lawrence, Donald
Lutzky, Jose
Miller, Wilson H.
Campbell, Katie M.
Delafont, Bruno
Marshall, Shannon
Mueller, Nancy
Robert, Caroline
Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma
title Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma
title_full Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma
title_fullStr Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma
title_full_unstemmed Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma
title_short Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma
title_sort author correction: pd-l1 blockade in combination with inhibition of mapk oncogenic signaling in patients with advanced melanoma
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360951/
https://www.ncbi.nlm.nih.gov/pubmed/34385448
http://dx.doi.org/10.1038/s41467-021-25285-0
work_keys_str_mv AT ribasantoni authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma
AT algazialain authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma
AT asciertopaoloa authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma
AT butlermarcuso authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma
AT chandrasunandana authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma
AT gordonmichael authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma
AT hernandezayaleonel authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma
AT lawrencedonald authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma
AT lutzkyjose authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma
AT millerwilsonh authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma
AT campbellkatiem authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma
AT delafontbruno authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma
AT marshallshannon authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma
AT muellernancy authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma
AT robertcaroline authorcorrectionpdl1blockadeincombinationwithinhibitionofmapkoncogenicsignalinginpatientswithadvancedmelanoma